The abstract is read at the publisher; the summary is JClub's.
Indole-3-propionic acid (IPA) directly modulates hepatic glucose production by remodeling mitochondrial metabolism, selectively reducing mitochondrial-dependent gluconeogenesis in primary hepatocytes.
- Why it matters: Gut microbiota metabolites are linked to metabolic health, but how specific microbial products regulate liver glucose metabolism is unclear.
- What they did: A focused indole metabolite screen in primary hepatocytes identified IPA; mechanistic tests assessed fuel use, redox balance, ATP availability, and urea cycle-linked activity, with signaling checked for proximal insulin/glucagon disruption.
- The result: In mice, short-term IPA improved fasting glycemia and glucose handling in Western diet-fed animals, and microbiome-depleted mice colonized with IPA-producing Clostridium sporogenes showed higher circulating IPA and better glucose tolerance than mice colonized with an IPA-deficient mutant strain.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.